CVnCoV – CureVac AG vs placebo
Local reactogenicity events
CVnCoV – CureVac AG leads to higher local reactogenicity eventsi compared with placebo (high certainty).
1 finding from 1 review
- RR 3.51 [3.24, 3.81]1 study · 3982 participantsHigh
CVnCoV – CureVac AG leads to higher local reactogenicity eventsi compared with placebo (high certainty).